Serum from COVID-19 patients promotes endothelial cell dysfunction through protease-activated receptor 2
Francesco Vieceli Dalla Sega, Francesca Fortini, Danilo Licastro, Simeone Dal Monego, Margherita Degasperi, Alessia Ascierto, Luisa Marracino, Paolo Severi, Maria D’Accolti, Irene Soffritti, Marta Brambilla, Marina Camera, Elena Tremoli, Marco Contoli, Savino Spadaro, Gianluca Campo, Roberto Ferrari, Elisabetta Caselli, Paola Rizzo
Topics & Concepts
Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ReceptorRheumatologyProteaseMedicineEndothelial dysfunctionInternal medicineImmunologyVirologyChemistryEnzymeBiochemistryDiseaseOutbreakInfectious disease (medical specialty)COVID-19 Clinical Research StudiesCOVID-19 Impact on ReproductionBlood Coagulation and Thrombosis Mechanisms